This profile was last updated on .
Is this you? Claim your profile.
National Institute for Biological Standards and Control
Blanche Lane South Mimms
Blanche Lane South Mimms,
NIBSC aims to maintain an effective capability for the standardisation and control of biologicals and to provide scientific advice and services of the highest quality to the Department of Health and associated bodies. It is therefore part of its strategy ...
Find other employees at this company (240)
(55 Total References)
NIBSC - About us
Professor Ian Feavers, Head of Bacteriology
Professor Ian ...
Professor Ian Feavers
Professor Ian Feavers
Professor Feavers is a Principal Scientist in the Division of Bacteriology at the National Institute for Biological Standards and Control, where he heads a team responsible for ensuring the safety and quality of meningococcal and pneumococcal vaccines.
In addition to this regulatory responsibility, his
group carries out research on meningococcal antigenic variation,population biology and the cell-surface proteome.
As a result, Ian
is closely associated with many of the current meningococcalvaccine developments and frequently advises the WHO, the EMEA, and companies on meningococcal and pneumococcalvaccine issues.
He is currently a Visiting Professor in the Centre for Molecular Microbiology and Infection at Imperial College London.
Tutors from the BioUpdate Foundation
Portrait photograph of Ian Feavers
Ian Feavers is a Principal Scientist in the Division of Bacteriology at the NIBSC, UK.
In addition to his
active research programme on the molecular genetics and immunology of meningococcal and pneumococcal antigens, his
laboratory is responsible for the control of meningococcal and pneumococcal vaccines.
With a broad experience of bacterial vaccines and molecular biology, he
is closely involved with a number of vaccine developments.
He regularly contributes to WHO and EU guidelines and is a member of the HPA's Vaccine Programme Board.
Currently they are: Professor Ian ...
Currently they are: Professor Ian Feavers (National Institute for Biological Standards and Control); and Professor Jodi A. Lindsay (St George's, University of London).
Currently a multi-disciplinary ...
Currently a multi-disciplinary collaborative project, developing a novel meningococcal vaccine is being developed with Dr Andrew Pollard (Paediatrics, University of Oxford), Professor Ian Feavers (National Institute for Biological Standards and Control), and Dr Jeremy Derrick (University of Manchester).